David Shaw’s Vicarious Surgical RBOT Stock Holding History

David Shaw’s Portfolio RBOT Stock Details RBOT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	–	Sell	-11,188	Closed	-$3.35M	–	5176
2021 Q2	$3.35M	Buy	+11,188	New	+$3.33M	﹤0.01%	2401

Other funds holding RBOT

VK Services Menlo Park, California $1.01M AUM 157.81% 1-Year Est. Return

Aspex Management (HK) Central, Hong Kong $8.89B AUM 39.91% 1-Year Est. Return

Comprehensive Financial Management Los Gatos, California $3.05B AUM 1.77% 1-Year Est. Return

Parian Global Management Pound Ridge, New York $30.8M AUM 51.25% 1-Year Est. Return

Ghisallo Capital Management Boston, Massachusetts $5.1B AUM 39.13% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Raymond James & Associates St Petersburg, Florida $164B AUM 33.91% 1-Year Est. Return

HRT Financial New York $54.8B AUM 81.03% 1-Year Est. Return

Chase Investment Counsel Charlottesville, Virginia $474M AUM 95.11% 1-Year Est. Return

Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return

David Shaw's RBOT Position: Q3 2021 in Review

David Shaw sold out of Vicarious Surgical (RBOT) in Q3 2021, closing a stake of 11,188 shares — an estimated $3.35M sold.

David Shaw first reported a position in RBOT in Q2 2021 and held it in 1 quarter. The position peaked at $3.35M in Q2 2021. 35 funds tracked by Wall St. Rank hold RBOT as of Q3 2021.

David Shaw reported no remaining Vicarious Surgical position as of Q3 2021 after selling out during the quarter.
David Shaw sold 11,188 Vicarious Surgical shares in Q3 2021, an estimated $3.35M.
David Shaw first reported a position in Vicarious Surgical in Q2 2021 and held it in 1 quarter.
David Shaw's Vicarious Surgical position peaked at $3.35M in Q2 2021.
35 funds tracked by Wall St. Rank held Vicarious Surgical as of Q3 2021.

Based on D.E. Shaw & Co's 13F filing for Q3 2021, filed 15 Nov 2021.